These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2402946)
21. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype. Bermúdez-Pirela V; Souki A; Cano-Ponce C; Bermúdez-Arias F; Mengual-Moreno E; Leal-Gonzalez E; Lemus-Antepaz M; de Bravo MC; de Díaz AA; de Pirela NL; Cano-Peñaloza R; Puche-Medina G; Arraiz N; Reyna-Villazmil N; Contreras F; Israili ZH; Valasco M Am J Ther; 2007; 14(2):213-20. PubMed ID: 17414592 [TBL] [Abstract][Full Text] [Related]
22. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Artery; 1980; 8(2):113-9. PubMed ID: 7458676 [TBL] [Abstract][Full Text] [Related]
23. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil. Sommariva D; Branchi A; Pini C; Scandiani L; Orlandi S; Fasoli A Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163 [TBL] [Abstract][Full Text] [Related]
24. [Characteristics of the lipid transport system in psoriasis]. Torkhovskaia TI; Fortinskaia ES; Ivanova LI; Nikitina NA; Zakharova TS; Kochetova MM; Kliuchnikova ZhI; Sharapova GIa; Khalilov EM Vopr Med Khim; 2002; 48(3):297-303. PubMed ID: 12243089 [TBL] [Abstract][Full Text] [Related]
25. Serum lipoprotein pattern after SAMe-treatment. Rini GB; Di Fede G; Rotolo G; Rizzo G; Mascellino MR; Affronti M; Delle Vedove G Boll Soc Ital Biol Sper; 1987 Oct; 63(10):919-22. PubMed ID: 3447603 [No Abstract] [Full Text] [Related]
26. [Plafibride treatment of hyperlipidemias type II and IV]. Soler J; Vinzia C; Gómez JM; Morató J Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212 [No Abstract] [Full Text] [Related]
27. Activity of serum lipase [EC 3.1.1.3] and the diversity of serum lipid profile in psoriasis. Pietrzak A; Lecewicz-Toruń B Med Sci Monit; 2002 Jan; 8(1):CR9-CR13. PubMed ID: 11782673 [TBL] [Abstract][Full Text] [Related]
28. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals]. Hutt V; Klör HU; Wechsler JG; Ditschuneit H J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054 [TBL] [Abstract][Full Text] [Related]
29. Early and late results of coronary artery bypass in patients with hyperlipoproteinemia. Hanson EC; Levine FH; Adzick NS; Lees RS; Daggett WM; Austen WG; Buckley MJ J Thorac Cardiovasc Surg; 1980 Mar; 79(3):372-80. PubMed ID: 6965512 [No Abstract] [Full Text] [Related]
30. [Antithrombogenic activity of the vascular wall, hemostasis, and rheological characteristics of blood in patients with unstable angina pectoris and various types of hyperlipoproteinemia]. Kirichuk VF; Voskoboĭ IV Ter Arkh; 2000; 72(12):47-50. PubMed ID: 11201832 [TBL] [Abstract][Full Text] [Related]
32. [Various characteristics of lipid metabolism disorders in obesity]. Kalmykov ZA Klin Med (Mosk); 1984 Aug; 62(8):107-9. PubMed ID: 6492701 [No Abstract] [Full Text] [Related]
33. Effect of moderate isocaloric modification of dietary carbohydrate on high-density lipoprotein composition and apolipoprotein A-1 turnover in humans. Zimmerman J; Eisenberg S; Kaufmann NA; Fainaru M; Oschry Y; Friedlander Y; Stein Y Isr J Med Sci; 1986 Feb; 22(2):95-104. PubMed ID: 3949491 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia]. Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Iwanejko J; Nowacki G Przegl Lek; 1987; 44(12):837-43. PubMed ID: 3330253 [No Abstract] [Full Text] [Related]
35. In vivo platelet activity and lipoprotein patterns in coronary artery disease. Goubran F; Maklady F; Saad M; el-Ashry M Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598 [TBL] [Abstract][Full Text] [Related]
36. The influence of a no-sugar diet on the composition of VLDL-fraction in patients with idiopathic hyperlipoprotenemia of type IIb and IV. Cybulska B; Naruszewicz M; Kłosiewicz-Latoszek L; Szostak WB; Chotkowska E Mater Med Pol; 1980; 12(4):286-92. PubMed ID: 7266054 [No Abstract] [Full Text] [Related]
37. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study. Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)]. Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Jamska B; Nowacki G Przegl Lek; 1987; 44(12):828-36. PubMed ID: 3330252 [No Abstract] [Full Text] [Related]
39. [Hyperlipoproteinemias in psoriasis]. Pfahl F; Rouffy J; Duperrat B; Puissant A Ann Dermatol Syphiligr (Paris); 1976; 103(1):15-22. PubMed ID: 999226 [TBL] [Abstract][Full Text] [Related]
40. [Functional status of thrombocytes and the anti-aggregative activity of the vascular wall in dyslipoproteinemias and ischemic heart disease]. Mikhailova IA; Lipovetskiĭ BM; Magracheva EIa; Gurevich VS Ter Arkh; 1989; 61(2):101-4. PubMed ID: 2727909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]